Trefoil Therapeutics
Pharmaceuticals, 4868 Almondwood Way, San Diego, California, 92130, United States, 1-10 Employees
Phone Number: +85********
Who is TREFOIL THERAPEUTICS
Trefoil Therapeutics is a clinical-stage biotechnology company driven by the mission to restore sight to the millions of people who live with corneal diseases through the advancement of r...
Read More
-
Headquarters: 4868 Almondwood Way, San Diego, California, 92130, United States
-
Date Founded: 2013
-
Employees: 1-10
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 8731
|
NAICS Code: 54 |
Show More
Does something look wrong? Fix it. | View contact records from TREFOIL THERAPEUTICS
Trefoil Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Trefoil Therapeutics
Answer: Trefoil Therapeutics's headquarters are located at 4868 Almondwood Way, San Diego, California, 92130, United States
Answer: Trefoil Therapeutics's phone number is +85********
Answer: Trefoil Therapeutics's official website is https://trefoiltherapeutics.com
Answer: Trefoil Therapeutics's revenue is $1 Million to $5 Million
Answer: Trefoil Therapeutics's SIC: 8731
Answer: Trefoil Therapeutics's NAICS: 54
Answer: Trefoil Therapeutics has 1-10 employees
Answer: Trefoil Therapeutics is in Pharmaceuticals
Answer: Trefoil Therapeutics contact info: Phone number: +85******** Website: https://trefoiltherapeutics.com
Answer: Trefoil Therapeutics is a clinical-stage biotechnology company driven by the mission to restore sight to the millions of people who live with corneal diseases through the advancement of regenerative therapies. Founded and led by scientists with deep experience in the ophthalmology field, Trefoil is advancing an approach that leverages novel technology to treat a number of different corneal diseases. The companys lead investigational medicine TTHX1114 has the potential to be first-in-class and is being studied for the treatment of corneal endothelial dystrophies and conditions via intracameral injection.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month